Literature DB >> 3472523

Chain-shortening of prostaglandin F2 alpha by rat liver peroxisomes.

U Diczfalusy, S E Alexson, J I Pedersen.   

Abstract

Liver peroxisomes were isolated from di(2-ethylhexyl)phthalate treated rats by isopycnic sucrose gradient centrifugation of a light mitochondrial fraction. Incubation of prostaglandin F2 alpha with purified peroxisomes resulted in conversion into a more polar product(s). In contrast, incubation with mitochondrial fractions and microsomal fractions under the same conditions did not result in any detectable conversion. The polar material obtained from a preparative incubation was purified by high performance liquid chromatography and characterized by radio-gas chromatography and gas chromatography-mass spectrometry. The structure of the polar compound was shown to be 5,7,11-trihydroxy-tetranorprost-9-enoic acid (tetranor-prostaglandin F1 alpha). Prostaglandin F2 alpha was thus chain-shortened by four carbon atoms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3472523     DOI: 10.1016/0006-291x(87)91439-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  The inborn errors of peroxisomal beta-oxidation: a review.

Authors:  R J Wanders; C W van Roermund; R B Schutgens; P G Barth; H S Heymans; H van den Bosch; J M Tager
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  The presence of acyl-CoA hydrolase in rat brown-adipose-tissue peroxisomes.

Authors:  S E Alexson; H Osmundsen; R K Berge
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

3.  Hydroxyeicosatetraenoic acid metabolism in cultured human skin fibroblasts. Evidence for peroxisomal beta-oxidation.

Authors:  J A Gordon; P H Figard; A A Spector
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

Review 4.  Prenatal and perinatal diagnosis of peroxisomal disorders.

Authors:  R B Schutgens; G Schrakamp; R J Wanders; H S Heymans; J M Tager; H van den Bosch
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

5.  Studies on peroxisomes of colonic mucosa in Crohn's disease.

Authors:  I Aimone-Gastin; S Cable; J M Keller; M A Bigard; B Champigneulle; P Gaucher; J L Gueant; M Dauça
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

Review 6.  Biochemistry of peroxisomes in health and disease.

Authors:  I Singh
Journal:  Mol Cell Biochem       Date:  1997-02       Impact factor: 3.396

7.  Metabolism of prostaglandin F2 alpha in Zellweger syndrome. Peroxisomal beta-oxidation is a major importance for in vivo degradation of prostaglandins in humans.

Authors:  U Diczfalusy; B F Kase; S E Alexson; I Björkhem
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

8.  Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.

Authors:  E Mayatepek; W D Lehmann; J Fauler; D Tsikas; J C Frölich; R B Schutgens; R J Wanders; D Keppler
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

9.  Genetic heterogeneity in the cerebrohepatorenal (Zellweger) syndrome and other inherited disorders with a generalized impairment of peroxisomal functions. A study using complementation analysis.

Authors:  S Brul; A Westerveld; A Strijland; R J Wanders; A W Schram; H S Heymans; R B Schutgens; H van den Bosch; J M Tager
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.